[
    [
        {
            "time": "2019-W05",
            "original_text": "每周药事2019年第5周:板块需要信心,继续看好超跌错杀个股",
            "features": {
                "keywords": [
                    "医药板块",
                    "信心",
                    "超跌",
                    "错杀",
                    "个股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "每周药事2019年第5周:板块需要信心,继续看好超跌错杀个股",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-W05",
            "original_text": "国产单抗类似药迎来上市元年，竞争之下比拼综合实力|【光大医药·周报】",
            "features": {
                "keywords": [
                    "国产单抗",
                    "上市元年",
                    "竞争",
                    "综合实力"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国产单抗类似药迎来上市元年，竞争之下比拼综合实力|【光大医药·周报】",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-Q1",
            "original_text": "东吴医药行业周观点:把握2019Q1医药股估值修复行情,继续推荐流感主题",
            "features": {
                "keywords": [
                    "医药行业",
                    "估值修复",
                    "流感主题",
                    "推荐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东吴医药行业周观点:把握2019Q1医药股估值修复行情,继续推荐流感主题",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]